Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Return on Equity (2021 - 2025)

Historic Return on Equity for iSpecimen (ISPC) over the last 5 years, with Q3 2025 value amounting to 6.65%.

  • iSpecimen's Return on Equity fell 48600.0% to 6.65% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.65%, marking a year-over-year decrease of 48600.0%. This contributed to the annual value of 1.97% for FY2024, which is 12500.0% down from last year.
  • According to the latest figures from Q3 2025, iSpecimen's Return on Equity is 6.65%, which was down 48600.0% from 9.75% recorded in Q2 2025.
  • iSpecimen's 5-year Return on Equity high stood at 0.26% for Q1 2022, and its period low was 9.75% during Q2 2025.
  • In the last 5 years, iSpecimen's Return on Equity had a median value of 0.74% in 2023 and averaged 2.01%.
  • As far as peak fluctuations go, iSpecimen's Return on Equity surged by 1300bps in 2022, and later tumbled by -81800bps in 2025.
  • iSpecimen's Return on Equity (Quarter) stood at 0.32% in 2021, then tumbled by -48bps to 0.48% in 2022, then tumbled by -101bps to 0.97% in 2023, then tumbled by -232bps to 3.2% in 2024, then tumbled by -108bps to 6.65% in 2025.
  • Its Return on Equity was 6.65% in Q3 2025, compared to 9.75% in Q2 2025 and 4.63% in Q1 2025.